Canada · Delayed Price · Currency is CAD Trulieve Cannabis Earnings Call Transcripts
Fiscal Year 2025
-
Reported $1.2B in 2025 revenue with 60% gross margin and record adjusted EBITDA of $427M. Wholesale grew 23%, and cash flow exceeded targets. Strategic focus includes Texas expansion, retail refreshes, and tech investments, with strong liquidity and readiness for regulatory changes.
-
Q3 revenue grew 1% year-over-year to $288M, with strong gross margin (59%) and adjusted EBITDA ($103M, up 7%). Cash flow and liquidity remain robust, while retail and wholesale segments expanded. Guidance calls for steady margins and at least $250M in operating cash for the year.
-
Federal rescheduling of cannabis is gaining momentum, with executive action expected soon, potentially easing research and tax burdens. In Florida, a revised adult use legalization campaign is underway, while consumer trends drive a focus on value products and new hemp-derived THC beverages. Capital allocation remains flexible, with refinancing and advocacy as priorities.
-
Second quarter revenue was $302 million, with strong 61% gross margin and $111 million adjusted EBITDA. Retail and wholesale channels showed growth, while net loss was impacted by 280E tax. Guidance anticipates stable margins and robust cash flow, with continued focus on reform and expansion.
-
First quarter revenue was $298 million with a 62% gross margin and $109 million adjusted EBITDA, driven by strong retail and wholesale performance. Cash flow and liquidity remain robust, with continued investment in branded products, new store openings, and reform initiatives. Guidance calls for stable margins and at least $250 million in operating cash flow for the year.
-
A leading multi-state cannabis operator highlighted its robust retail expansion, strong customer retention, and disciplined margin management. Growth is driven by operational efficiencies, technology investments, and a customer-centric approach, while regulatory and legislative developments are closely monitored.
Fiscal Year 2024
-
Delivered strong 2024 results with 5% revenue growth, improved margins, and record cash flow. Expanded retail and wholesale, launched a new THC beverage, and maintained a robust balance sheet. Outlook for 2025 includes continued margin strength, disciplined capital allocation, and strategic growth initiatives.
-
Q3 revenue rose 3% year-over-year to $284M, with gross margin at 61% and adjusted EBITDA up 24%. Positioned for Florida adult-use legalization, the company invested in retail, production, and technology, while maintaining strong cash flow and margin discipline.
-
Retail traffic rose 3% in Q2, with stable consumer trends and strong loyalty program adoption. Ohio's adult-use launch saw high demand and no supply issues, while Florida's Amendment 3 campaign shows strong polling and operational readiness for rapid expansion if passed.
-
Q2 revenue and margins exceeded guidance, driven by retail and wholesale growth, cost controls, and infrastructure investments. The company remains well-positioned for Florida adult-use legalization, with strong cash flow, expanding retail footprint, and continued focus on technology and customer loyalty.